13F HOLDINGS REPORT (Amended)
Exome Asset Management LLC
Quarter ended Q1 2025 · Filed May 16, 2025 · Accession 0001420506-25-001316
Total Value
$112.5M
Positions
59
Other Managers
0
Confidential Omitted
No
Holdings (59)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BRIDGEBIO PHARMA INC | BBIO | 165,496 | $5.7M | 5.09% |
| 2 | GUARDANT HEALTH INC | GH | 127,182 | $5.4M | 4.82% |
| 3 | GERON CORP | GERN | 3,215,457 | $5.1M | 4.54% |
| 4 | ASTRAZENECA PLC | AZN | 32,534 | $4.7M | 4.20% |
| 5 | CYTOKINETICS INC | CYTK | 103,483 | $4.2M | 3.70% |
| 6 | SYNDAX PHARMACEUTICALS INC | SNDX | 337,198 | $4.1M | 3.68% |
| 7 | IONIS PHARMACEUTICALS INC | IONS | 135,616 | $4.1M | 3.64% |
| 8 | ELI LILLY & CO | LLY | 4,673 | $3.9M | 3.43% |
| 9 | COGENT BIOSCIENCES INC | COGT | 621,678 | $3.7M | 3.31% |
| 10 | INTUITIVE SURGICAL INC | ISRG | 6,358 | $3.1M | 2.80% |
| 11 | SOLENO THERAPEUTICS INC | SLNO | 43,441 | $3.1M | 2.76% |
| 12 | AKERO THERAPEUTICS INC | 00973Y108 | 76,379 | $3.1M | 2.75% |
| 13 | DISC MEDICINE INC | IRON | 61,656 | $3.1M | 2.72% |
| 14 | VIRIDIAN THERAPEUTICS INC | VRDN | 217,294 | $2.9M | 2.60% |
| 15 | REGENXBIO INC | RGNX | 405,281 | $2.9M | 2.58% |
| 16 | REPLIMUNE GROUP INC | REPL | 294,846 | $2.9M | 2.56% |
| 17 | SCHOLAR ROCK HLDG CORP | SRRK | 84,339 | $2.7M | 2.41% |
| 18 | DYNE THERAPEUTICS INC | DYN | 258,391 | $2.7M | 2.40% |
| 19 | NATERA INC | NTRA | 18,650 | $2.6M | 2.34% |
| 20 | 89BIO INC | 282559103 | 353,882 | $2.6M | 2.29% |
| 21 | PENUMBRA INC | PEN | 9,000 | $2.4M | 2.14% |
| 22 | SAVARA INC | SVRA | 836,397 | $2.3M | 2.06% |
| 23 | ANAPTYSBIO INC | ANABV | 116,623 | $2.2M | 1.93% |
| 24 | TRAVERE THERAPEUTICS INC | TVTX | 118,017 | $2.1M | 1.88% |
| 25 | CENTESSA PHARMACEUTICALS PLC | CNTA | 142,744 | $2.1M | 1.82% |
| 26 | GE HEALTHCARE TECHNOLOGIES I | GEHC | 25,400 | $2.1M | 1.82% |
| 27 | FULCRUM THERAPEUTICS INC | FULC | 689,137 | $2.0M | 1.76% |
| 28 | STRUCTURE THERAPEUTICS INC | GPCR | 102,944 | $1.8M | 1.58% |
| 29 | IMMUNOME INC | IMNM | 263,841 | $1.8M | 1.58% |
| 30 | BEIGENE LTD | BEIGF | 6,500 | $1.8M | 1.57% |
| 31 | CRINETICS PHARMACEUTICALS IN | CRNX | 51,295 | $1.7M | 1.53% |
| 32 | EDGEWISE THERAPEUTICS INC | EWTX | 71,438 | $1.6M | 1.40% |
| 33 | DR REDDYS LABS LTD | 256135203 | 117,500 | $1.5M | 1.38% |
| 34 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 289,690 | $1.5M | 1.37% |
| 35 | KARYOPHARM THERAPEUTICS INC | KPTI | 2,000,000 | $1.5M | 1.35% |
| 36 | NEKTAR THERAPEUTICS | NKTR | 2,232,453 | $1.5M | 1.35% |
| 37 | ARVINAS INC | ARVN | 195,295 | $1.4M | 1.22% |
| 38 | GOSSAMER BIO INC | GOSS | 1,097,999 | $1.2M | 1.07% |
| 39 | TREVI THERAPEUTICS INC | TRVI | 163,738 | $1.0M | 0.92% |
| 40 | MBX BIOSCIENCES INC | MBX | 133,113 | $982,374 | 0.87% |
| 41 | BIOHAVEN LTD | BHVN | 39,900 | $959,196 | 0.85% |
| 42 | ALVOTECH | ALVOW | 90,100 | $871,267 | 0.77% |
| 43 | VYNE THERAPEUTICS INC | VYNE | 462,801 | $731,225 | 0.65% |
| 44 | ESTABLISHMENT LABS HLDGS INC | ESTA | 13,100 | $534,546 | 0.48% |
| 45 | BIOCRYST PHARMACEUTICALS INC | BCRX | 60,600 | $454,500 | 0.40% |
| 46 | ELEDON PHARMACEUTICALS INC | ELDN | 114,145 | $386,952 | 0.34% |
| 47 | AKEBIA THERAPEUTICS INC | AKBA | 189,087 | $363,047 | 0.32% |
| 48 | TRAVERE THERAPEUTICS INC | TVTX | 110,000 | $231,000 | 0.21% |
| 49 | ALDEYRA THERAPEUTICS INC | ALDX | 100,000 | $190,000 | 0.17% |
| 50 | NUVATION BIO INC | NUVB | 96,311 | $169,507 | 0.15% |
| 51 | CYTOKINETICS INC | CYTK | 23,000 | $141,450 | 0.13% |
| 52 | SPRINGWORKS THERAPEUTICS INC | 85205L907 | 37,500 | $129,375 | 0.12% |
| 53 | RHYTHM PHARMACEUTICALS INC | RYTM | 40,000 | $70,000 | 0.06% |
| 54 | APREA THERAPEUTICS INC | APRE | 28,972 | $59,103 | 0.05% |
| 55 | GOSSAMER BIO INC | GOSS | 100,000 | $47,500 | 0.04% |
| 56 | NEKTAR THERAPEUTICS | NKTR | 75,000 | $22,500 | 0.02% |
| 57 | ROIVANT SCIENCES LTD | ROIV | 75,300 | $15,060 | 0.01% |
| 58 | VERU INC | VERU | 60,000 | $900 | 0.00% |
| 59 | SOLENO THERAPEUTICS INC | SLNO | 11,000 | $275 | 0.00% |